MedPath

ECT Schizophrenia Serotonin Study

Conditions
Schizophrenia
Registration Number
NCT00278668
Lead Sponsor
Sha'ar Menashe Mental Health Center
Brief Summary

We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT

Detailed Description

We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria

Participants must meet DSM-IV criteria for schizophrenia, as assessed by the Structured Clinical Interview - Patient Version (SCID) (First et al., 1995).

Ages 18 -55 Men and/or women -

Exclusion Criteria
  1. History of neurological disorders, active substance abuse in the previous 3 months.

  2. Estimated IQ less then 70.

  3. SSRIs treatment 4 weeks prior to the study.

  4. Any subject suffering from inflammatory fever disease will be excluded from the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath